Statine in der Primärprävention, ja oder nein? - Metaanalysen mit unterschiedlichen Resultaten

[Article in German]

K Woitzek¹

Affiliations

Comment

[Article in German]

K Woitzek. Praxis (Bern 1994). 2011.

. 2011 Jul 6;100(14):869-71.

doi: 10.1024/1661-8157/a000596.

K Woitzek¹

¹ Horten Zentrum für praxisorientierte Forschung und Wissenstransfer, Zürich. katja.woitzek@usz.ch

No abstract available

Comment on

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N. Ray KK, et al. Arch Intern Med. 2010 Jun 28;170(12):1024-31. doi: 10.1001/archinternmed.2010.182. Arch Intern Med. 2010. PMID: 20585067 Review.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
Cholesterol Treatment Trialists’ (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Cholesterol Treatment Trialists’ (CTT) Collaboration, et al. Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8. Lancet. 2010. PMID: 21067804 Free PMC article.